Key points are not available for this paper at this time.
Diabetic kidney disease (DKD) is the leading cause of chronic kidney disease and end-stage renal disease, and is characterized by persistent proteinuria and decreased glomerular filtration rate.Despite extensive efforts, the increasing incidence highlights the urgent need for more effective treatments.Histone methylation is a crucial epigenetic modification, and its alteration can destabilize chromatin structure, thereby regulating the transcriptional activity of specific genes.Histone methylation serves a substantial role in the onset and progression of various diseases.In patients with DKD, changes in histone methylation are pivotal in mediating the interactions between genetic and environmental factors.Targeting these modifications shows promise in ameliorating renal histological manifestations, tissue fibrosis and proteinuria, and represents a novel therapeutic frontier with the potential to halt DKD progression.The present review focuses on the alterations in histone methylation during the development of DKD, systematically summarizes its impact on various renal parenchymal cells and underscores the potential of targeted histone methylation modifications in improving DKD outcomes. Contents1. Introduction 2. Regulation of histone methylation constitutes a sophisticated, dynamic and precise network system 3. Distinct function of histone methylation in the pathogenesis and progression of DKD 4. Therapeutic approaches aimed at modulating histone methylation in the context of DKD 5. Conclusions
Qu et al. (Tue,) studied this question.